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α-Synuclein (α-syn) is an intrinsically disordered protein abundantly distributed in
presynaptic terminals. Aggregation of α-syn into Lewy bodies (LB) is a molecular
hallmark of Parkinson’s disease (PD). α-Syn features an extreme conformational
diversity, which adapts to different conditions and fulfills versatile functions. However,
the molecular mechanism of α-syn transformation and the relation between different
structural species and their functional and pathogenic roles in neuronal activities and
PD remain unknown. In this mini-review, we summarize the recent discoveries of α-syn
structures in the membrane-bound state, in cytosol, and in the amyloid state under
physiological and pathological conditions. From the current knowledge on different
structural species of α-syn, we intend to find a clue about its function and toxicity
in normal neurons and under disease conditions, which could shed light on the PD
pathogenesis.
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Abnormal aggregation of α-synuclein (α-syn) is closely associated with Parkinson’s disease
(PD). The aggregated α-syn was found dominantly in Lewy bodies (LB) as the hallmark of PD
(Spillantini et al., 1997) and other syncleinopathies such as dementia with LB, and multiple system
atrophy. α-Syn also co-aggregates with amyloid β (Aβ) in the brain tissue of patients diagnosed
as Alzheimer’s disease (AD; Uéda et al., 1993). Various point mutations of gene SNCA (encoding
α-syn), and the duplication and triplication of α-syn locus all lead to dominant familial PD
(Polymeropoulos et al., 1997; Krüger et al., 1998; Singleton et al., 2003; Chartier-Harlin et al., 2004;
Zarranz et al., 2004; Mizuno et al., 2012; Lesage et al., 2013; Proukakis et al., 2013; Pasanen et al.,
2014; Ferese et al., 2015). Despite its crucial role in pathogenesis, α-syn is believed to perform
biological functions under physiological conditions because of its extremely high abundance in
primary neurons, representing 1% of the total protein (Mizuno et al., 2012). It mainly gathers
in presynaptic terminals and associates with reserve pool of synaptic vesicles (Maroteaux et al.,
1988; Larsen et al., 2006; Nemani et al., 2010). α-Syn is capable of clustering synaptic vesicles and
facilitating the assembly of soluble N-ethylmaleimide-sensitive factor attachment protein receptor
(SNARE) complex (Burré et al., 2010). Corresponding to its diverse roles under both physiological
and pathological conditions, various forms of α-syn, such as monomer, oligomer, and fibril, were
found in cytosol, on membrane, and in the amyloid aggregation states (Iwai et al., 1995; Burré
et al., 2014; Theillet et al., 2016). Therefore, to reveal the structural variations of α-syn is of great
importance to understand its physiological function and pathogenic property.
α-Syn is an intrinsically disordered protein. It consists of 140 amino acids and is divided into
three regions (Figure 1A). Each region has distinct physiochemical property corresponding to
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FIGURE 1 | Structural models of α-synuclein (α-syn) in different states. (A) The primary sequence of α-syn with three regions highlighted in blue, orange and
red, respectively. The three familial Parkinson’s disease (PD)-related mutations are denoted. (B) The structural model of an α-syn monomer on unilamellar vesicles
(from Jao et al., 2008 reprinted with permission). The continuing helix (residues 9–89) is colored in green. (C) The helical wheel model of α-syn membrane-binding
region from residue 9 to 90. (D) The structure of a micelle-bound α-syn monomer (Protein Data Bank ID: 1XQ8). The three regions are color-coded according to (A).
(E) The geometry and arrangement of a single layer of fibril core from three α-syn fibrillar models in cartoon form (Vilar et al., 2008; Dearborn et al., 2015; Rodriguez
et al., 2015) viewed perpendicular to the fibril axis. The top and bottom ones both contain single α-syn monomer per layer of protofilament. The middle one contains
two α-syn monomers paired via steric-zipper-like interaction. The different regions are color-coded according to (A). (F) The atomic structure of α-syn non-amyloid β
component (NAC) fibril core obtained from electron diffraction (Protein Data Bank ID: 4RIL). (G) The structural model of an α-syn fibril determined by solid-state
nuclear magnetic resonance (NMR; Protein Data Bank ID: 2N0A). The three regions are color-coded according to (A). The side chains of the fibril core (residues
46–54 and 63–96) are shown in stick representation. (H) The architecture of an α-syn oligomer formed in the presence of supported lipid bilayers probed by atomic
force microscopy (AFM; from Quist et al., 2005 reprinted with permission). (I) The structural model of two types of soluble α-syn oligomers (upper for 10S and
bottom for 15S oligomer subgroups) measured by cryoEM (from Chen et al., 2015 reprinted with permission).
the amino acid composition. The N-terminal region (residues
1–60) is capable of forming an amphipathic helix which is a
typical conformation for membrane recognition and association
(Segrest et al., 1990; Jao et al., 2008). Several mutations
found in familial PD, such as A53T (Polymeropoulos et al.,
1997), E46K (Zarranz et al., 2004), and A30P (Krüger et al.,
1998), are located in this region, indicating the importance of
membrane binding for the function of α-syn. The central region
containing residues 61–95 is well known as the non-amyloid
β component (NAC) firstly identified in AD senile plaques
(Uéda et al., 1993). This region features a high propensity to
form a β-rich conformation and is highly aggregation-prone
(Uversky et al., 2001). Different types of post-translational
modifications within this region show distinct effects on
modulating α-syn aggregation. For example, glycosylation
at T72 and phosphorylation at S87 have been reported to
block α-syn aggregation (Paleologou et al., 2014; Marotta
et al., 2015). The C-terminal region with residues 96–140 is
rich of proline and negatively charged residues including 10
glutamates and five aspartates, which is a common characteristic
found in intrinsically disordered proteins to maintaining
solubility. On the structural front, several important questions
remain unclear. How do the three regions independently and
cooperatively accomplish the formation and conversion of
α-syn structures in different states? What are the common
structural features of α-syn in different states? How to correlate
the biological function and cellular toxicity of α-syn with the
different structures or structural transformation? Regarding
these important fundamental questions, we summarize
the current knowledge of α-syn structures in the states of
membrane binding, cytosol, and amyloid aggregation. We also
discuss the relationship between the different structural
states and their physiological function and pathological
toxicity.
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THE STRUCTURE OF MEMBRANE-BOUND
α-Syn
α-Syn is capable of binding to membrane upon the structural
transition from random coil to α-helix (Davidson et al., 1998).
The N-terminal region of α-syn contains seven copies of
a tandem 11-residue pseudorepeat, which is a characteristic
of lipid-binding domains found in apolipoproteins (George
et al., 1995). By using electron paramagnetic resonance
(EPR) spectroscopy and nuclear magnetic resonance (NMR)
spectroscopy, α-syn was found to adopt a continuous helix from
residue 9–89 on the surface of unilamellar vesicles (Figure 1B;
Jao et al., 2008; Bodner et al., 2009). As shown in the helical
wheel (Figure 1C), the helix features four interfaces with
distinct properties. The interface in pink is mainly composed of
hydrophobic residues and is buried inside the membrane. The
green interface containing several Glu residues is exposed to the
solvent. Meanwhile, the two white colored strips on the two sides
of the helix feature 11 positively charged Lys residues which
correspond to the electrostatic interaction with the head groups
of lipids. Indeed, it was reported that α-syn only recognizes
and binds to the membrane composed of phospholipids with
negatively charged head groups such as PS and PA (Eliezer et al.,
2001; Jain et al., 2013).
A recent work shows that, upon membrane recognizing
and binding, the first 25 amino acids are involved in a well-
defined helical structure acting as a membrane anchor to
initiate docking of α-syn on the membrane (Fusco et al.,
2014). Meanwhile, the rest of the helix (residues 26–97)
exhibits a structural flexibility, and transforms between helix
and random coil depending on the lipid composition (Fusco
et al., 2014). This region is believed to determine the binding
affinity of α-syn to membrane. Upon binding to a highly
curved membrane surface, the continuous helix breaks into
two individual helices (Rao et al., 2010). The structure of
α-syn bound to sodium dodecyl sulfate (SDS) micelles was
determined by using solution NMR (Ulmer et al., 2005).
Unlike the continuous helical structure found in the liposome-
bound state, SDS-bound α-syn forms two slightly curved α-
helices (residues 3–37 and 45–92) exhibiting a hairpin structure
connected by a stretched five-residue linker (Figure 1D).
The circle diameters of the two curved α-helices are ∼153
Å and ∼82 Å, respectively, which are much smaller than that
of presynaptic vesicles (∼400–500 Å). No direct interactions
were observed between the two helices. Molecular dynamics
(MD) simulations show that, depending on the curvature
and property of the membrane surface, α-syn senses and
adapts to membrane by adjusting the circle diameters and the
relative positions of the two helices (Drescher et al., 2008;
Ferreon et al., 2009; Lokappa and Ulmer, 2011; Robotta et al.,
2011). In the membrane-bound state, the C-terminal region
is highly flexible with no association to the membrane. In
addition, a recent study indicated that α-syn forms a multimer
on the membrane by using fluorescence resonance energy
transfer (FRET) and chemical cross-linking (Burré et al., 2014).
However, the atomic structural information of this multimer is
absent.
THE FUNCTION OF α-Syn IN SYNAPTIC
TRANSMISSION
Studies have suggested that α-syn functions in various aspects
of synaptic transmission. Burré et al. (2010) have found
that α-syn can facilitate neuronal SNARE complex assembly,
which is fulfilled by the direct interaction between the highly
flexible and negatively charged C-terminal region of α-syn and
the N-terminus of synaptobrevin-2/VAMP2 (vesicle associated
membrane protein 2; Burré et al., 2010). Synaptobrevin-
2/VAMP2 is a key component of SNARE complex residing
on the synaptic vesicles. Membrane anchoring of α-syn via
its N-terminal region is also essential for the process. The
same group has also hypothesized that, in compensation
for cysteine string protein α (CSPα), α-syn can act as a
neuroprotective chaperone to maintaining the SNARE function
(Chandra et al., 2005).
Complementary to the in vivo studies, in vitro assays
involving protein-reconstituted vesicles were performed to
investigate the function of α-syn in synaptic transmission
(Brunger et al., 2015). Diao et al. (2013) showed that α-syn
significantly promotes the clustering of protein-reconstituted
liposomes—minimal mimics of synaptic vesicles, while with
little effect on Ca2+-triggered fusion in a single vesicle-vesicle
system with reconstituted neuronal SNAREs, synaptotagmin-1,
and complexin-1. The function of vesicle-clustering was observed
for both recombinant as well as native α-syn purified from
mouse brains, and was confirmed by in vivo studies (Wang
et al., 2014). The clustering of synaptic vesicles by α-syn
could promote the neuronal trans-SNARE complex formation
and provide a ‘‘buffer’’ of synaptic vesicles for synaptic
transmission.
α-Syn was also found to reduce ensemble lipid mixing
(Dewitt and Rhoades, 2013). Through advanced single vesicle
technique, others found that α-syn reduces the ensemble
lipid mixing by blocking vesicle association (Choi et al.,
2013; Lai et al., 2014). α-Syn was also shown to jam the
synaptic vesicle trafficking on the ‘‘priming’’ step (Larsen
et al., 2006). Overexpression of α-syn in chromaffin cells
resulted in the accumulation of docked vesicles without
being secreted (Larsen et al., 2006). Another study showed
that α-syn impairs the re-clustering of synaptic vesicles
on the vesicle recycling step after endocytosis in the
rodent hippocampus (Nemani et al., 2010). Therefore,
α-syn can play multiple roles throughout the process of
synaptic vesicle trafficking, including vesicle clustering,
priming, fusion (assembly of SNARE complex), and
recycling (disassembly of SNARE complex; Lashuel et al.,
2013).
These functions of α-syn are all associated with membrane
binding, while the structural information of membrane-
bound α-syn described in the early section is too limited
to explain the underling mechanism. However, the versatile
functions may reflect a dynamic conformational transition
of α-syn possibly combined with an association and
dissociation of α-syn multimers upon interacting with
membranes. Therefore, it is reasonable to deduce that α-syn
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is regulated by some unidentified cofactors to ensure proper
structural conformations, cellular localization, and local
concentration upon membrane binding and release. The failure
of regulation might result in dysfunction of α-syn and amyloid
aggregation.
α-Syn IN CYTOSOL UNDER
PHYSIOLOGICAL CONDITIONS
Although α-syn exhibits a strong membrane-binding capability,
accumulating evidence show that α-syn dominantly exists in
cytosol instead (Binolfi et al., 2012; Fauvet et al., 2012; Theillet
et al., 2016). However, studies of α-syn in cytosol gained
conflicting results. Recombinant α-syn purified from E. coli
showed an unstructured monomeric species (Weinreb et al.,
1996). Endogenous α-syn extracted from neurons (M17D),
HeLa, brain tissues, and human red blood cells was characterized
dominantly as a tetramer featuring an α-helical bundle
structure that were evidenced by multiple approaches including
native PAGE, cross linking, transmission electron microscopy
(TEM), scanning transmission electron microscopy (STEM)
and sedimentation equilibrium analytical ultracentrifugation
(SE-AUC; Chen et al., 2007; Bartels et al., 2011). However,
following studies by other biophysical methods (e.g., light
scattering and NMR) indicated that the ‘‘tetramer’’ species
was actually a minority compared to dominant unstructured
monomers (Binolfi et al., 2012; Burré et al., 2013; Gurry et al.,
2013). Recently, Theillet et al. (2016) have shown that α-
syn remains as a monomer by using in vivo NMR (Theillet
et al., 2016). They transformed mammalian neuronal and non-
neuronal cells with 15N labeled α-syn by electroporation, and
found that most regions of α-syn remain unstructured with a
high flexibility. An intriguing observation is that, the intensity
of NMR signals of the N-terminal 10 residues and a few
residues in the central and C-terminal regions of α-syn dropped
dramatically, indicating an interaction between α-syn and some
unidentified molecules in vivo (Theillet et al., 2016). Theillet
et al. (2016) tested the interactions of Ficoll, BSA, lysozyme,
and liposome with α-syn in vitro. However, none of them can
fully resemble the in vivo observation. The controversial results
of the structural studies on the native state of α-syn in cytosol
suggest a significant morphological plasticity. It is plausible
that the structure of α-syn in cytosol highly depends on its
binding partners such as metabolites, lipids, and chaperones. The
identification of these binding partners of α-syn in cytosol would
be a notable step forward to understanding the physiological
function of α-syn.
POLYMORPHIC STRUCTURES OF THE
PARKINSON’S ASSOCIATED α-Syn
AMYLOID AGGREGATION
Under certain conditions, α-syn spontaneously enters the
amyloid state and self-assembles into amyloid oligomers and
fibrils. Amyloid fibril of α-syn was identified as a prominent
component of LB, a molecular hallmark of PD (Spillantini et al.,
1997). It remains controversial whether the α-syn amyloids
are the consequence or cause of PD. Therefore, structural
understanding of α-syn amyloids is crucial to imply the
cytotoxicity of the amyloid aggregates and to reveal themolecular
mechanism of the disease. However, given the intrinsic instability
and polymorphic nature of amyloid oligomers (Stroud et al.,
2012; Gurry et al., 2013), and insolubility and heterogeneity of
amyloid fibrils (Heise et al., 2005; Liu et al., 2012), it remains
challenging to determine the atomic structures of full-length
α-syn in either form.
Despite the difficulties, efforts have been made towards the
atomic structures of α-syn fibrils by using different approaches.
The fibril core was firstly mapped by proteinase K digestion of
recombinant α-syn and α-syn extracted from synucleinopathic
brains (Miake et al., 2002). The fibril core contains residues
31–109, covering the entire NAC region and part of the N- and
C-terminal regions. The structural model of α-syn protofilament
was calculated by the structural constraints derived from EPR
(Der-Sarkissian et al., 2003; Chen et al., 2007) and solid-state
NMR experiments (Heise et al., 2005; Vilar et al., 2008). This
model comprises a five-layered β-sandwich, which generates five
layers of parallel, in-register β-sheets as incorporated into a
protofilament. Furthermore, protofilaments align with or twist
around each other to form a fibril (Figure 1E, upper). This model
sets up a starting point toward the structural understanding of
α-syn amyloid aggregation.
Recently, micro-electron diffraction (MicroED) has been
applied to the micro-sized and nano-sized crystals of amyloid-
forming peptides. Atomic structures of the segments from
α-syn fibril core, NACore (residues 68–78), and PreNAC
(residues 47–56), were determined at 1.4 Å resolution (Rodriguez
et al., 2015). The structure of NACore in the fibrillar form
reveals a typical steric zipper spine structure featuring a high
complimentary and dry interface formed by Thr and Ile of the
two adjacent 11 mers (Figure 1F). Importantly, the NACore
fibril resembles the cytotoxicity of the full-length α-syn fibril
in the PC12 cells. Based on the atomic structures of NACore
and PreNAC, a hypothetical model of α-syn fibril was built. In
this model, each α-syn monomer forms an antiparallel β-sheet
structure stabilized by a hetero-zipper-like interaction, and stacks
on top of each other to form a protofilament (Figure 1E,
middle). Two protofilaments are paired simultaneously by
zipper-like interactions of residues V70, T72, V74, and A76
(Figure 1E, middle). The model explains the disease-related
mutation A53T, which could form a tighter steric zipper interface
so that stabilizes the toxic fibril structure. This is also in
consistence with the highly aggregation-prone nature of A53T,
which may gain higher resistance to degradation than the
wildtype.
Another structural model of α-syn protofilament was
proposed based on cryo-EM and dark-filed STEM studies
(Dearborn et al., 2015). Each protofilament consists of two
v-shaped β-serpentines formed by three antiparallel β-strands
(Figure 1E, bottom). The entwined protofilaments may further
assemble into mature fibrils. However, the resolution of the
structural model is low (∼30 Å) owing to the heterogeneity
of the fibril samples. Detailed structural information is
still beyond reach from this study. Most recently, a three-
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FIGURE 2 | The schematics of different species of α-syn under physiological and pathogenic conditions. Monomeric α-syn induces vesicle clustering and
chaperones soluble n-ethylmaleimide-sensitive factor attachment protein receptor (SNARE)-complex assembling via binding to the SNARE protein
synaptobrevin-2/VAMP2 and membrane under the physiological condition. While, under the pathogenic condition, α-syn self-assembles into amyloid oligomers and
fibrils. Different types of α-syn oligomers may impair vesicle association, and insert into the membrane by forming pore-like oligomers.
dimensional structural model of full-length α-syn fibril was
determined by solid-state NMR and STEM, and validated
by fibril diffraction (Figure 1G; Tuttle et al., 2016). The
root-mean-square (RMS) deviation of the 10 lowest-energy
structures of fibril core (residues 46–54 and 63–96) is 2.0
Å for all heavy atoms. The structure features a Greek-
key topology which is entirely different from previous fibril
structures. The fibril core is formed by parallel in-register β-
sheets, and stabilized by hetero-steric zippers, salt-bridges, a
glutamine ladder and hydrophobic interactions. Notably, the
fibrils used in this structural study can induce aggregation of
endogenous α-syn to form phosphorylated inclusions, and cause
neuronal injury and death of primary hippocampal neurons.
The follow-up study on structure-toxicity relationship will
be valuable to elucidate the structural basis of α-syn fibril
pathology.
The diverse structures of α-syn fibril support the polymorphic
nature of α-syn fibrils formed under different conditions.
Recently, two strains of α-syn fibrils with distinct morphologies
were reported (Bousset et al., 2013). They exhibit different
neurotoxicity and cell-to-cell transmission properties, and thus
lead to distinct pathologies. Another study shows that α-syn is
capable of cross-seeding the aggregation of tau protein, which
is one of the main amyloid proteins in AD, in vivo (Guo
et al., 2013). Notably, tau proteins cross-seeded by α-syn fibrils
prepared from various protocols exhibit different properties and
result in distinct histopathological and behavioral phenotypes
in mice. Therefore, it would be valuable to link structural
models of α-syn fibrils with their pathogenic counterparts,
which may possibly imply the difference of the cellular
effects, and bridge the gap between structures and neuronal
toxicity.
The amyloid oligomers of α-syn were reported to cause
cell death in cells and model systems such as C. elegans and
Drosophila (Karpinar et al., 2009). In contrast to the fibrillar
form of α-syn, the structural details of α-syn oligomers remain
absent owing to their transient and labile properties. Several
studies report that α-syn oligomers feature a β-rich structure with
either parallel or antiparallel β-sheets. An annular channel-like
architecture of oligomers formed by wild-type α-syn or A53T
mutant was observed in the presence of lipid by atomic force
microscopy (AFM; Figure 1H; Quist et al., 2005) and in solution
by EM (Lashuel et al., 2002). It indicates that α-syn oligomers
may poison cells by forming ion channels on the membrane or
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disrupting the membrane integrity. Through cryo-EM, another
group characterized α-syn oligomer structures showing two
types of annular oligomers in solution (Figure 1I; Chen et al.,
2015). The cavity in these annular structures may accommodate
substrates such as metals, fatty acids, and other small molecules.
Interestingly, α-syn point mutations E35K and E57K, rather
than A30P and E46K, prefer to form annular oligomers, are
more prone to form fibrils, and exhibit potential neuronal
toxicity in the rat substantia nigra (SN) region (Winner et al.,
2011). Most recently, a label-free single molecular study revealed
that lipids facilitate α-syn oligomerization without altering the
aggregation pathway (Hu et al., 2016). These results together
highlight the potential importance of annular oligomers in
pathogenesis.
OUTLOOK
The research works summarized here show a rapid advance
of our knowledge on α-syn functions and structures under
physiological and pathogenic conditions (Figure 2). Meanwhile,
several fundamental questions remain to be answered, such
as the structural basis of α-syn conformational transition, the
correlation between structural models and the cellular roles
of α-syn, as well as unknown endogenous cofactors (e.g.,
metabolites, lipids, and chaperones) regulating the structural
transformation of α-syn upon environmental changes. New
technologies would be extremely helpful to address these
questions. For example, integrating new imaging techniques with
the current approaches of structural determination would allow
a high resolution structural analysis of different α-syn structural
species in test tubes, cells, and living tissues. Novel cellular and
biochemical approaches are required to discover the endogenous
molecules that interplay with different α-syn conformations. As
the answers to these questions emerge, a clear picture of the
physiological function and pathogenic behavior of α-syn will be
within reach, which may further provide new molecular targets
and drug candidates for therapeutic intervention against α-syn
related diseases.
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